An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Surmodics, Inc. (Nasdaq: SRDX) will report its second quarter of fiscal 2024 financial results on May 1, with a live webcast and conference call to discuss the achievements. The earnings call will be at 7:00 am (CT) and can be accessed through the Company's website. An audio replay will be available until May 15.
Surmodics, Inc. (Nasdaq: SRDX) presenterà i risultati finanziari del secondo trimestre dell'anno fiscale 2024 il 1° maggio, con una trasmissione web e una conferenza telefonica per discutere i risultati ottenuti. La conferenza sugli utili si terrà alle 7:00 (CT) e sarà possibile seguirla tramite il sito web dell'azienda. Una registrazione audio sarà disponibile fino al 15 maggio.
Surmodics, Inc. (Nasdaq: SRDX) informará sobre sus resultados financieros del segundo trimestre del año fiscal 2024 el 1 de mayo, con una transmisión en vivo y una llamada de conferencia para discutir los logros. La llamada de resultados será a las 7:00 am (CT) y se podrá acceder a través del sitio web de la Compañía. Una repetición de audio estará disponible hasta el 15 de mayo.
Surmodics, Inc. (나스닥: SRDX)는 2024 회계연도 2분기 재무 결과를 5월 1일에 발표할 예정이며, 성과를 논의하기 위한 생방송 웹캐스트와 컨퍼런스 콜이 진행됩니다. 수익 콜은 오전 7시(CT)에 시작되며 회사 웹사이트를 통해 접속할 수 있습니다. 오디오 재생은 5월 15일까지 가능합니다.
Surmodics, Inc. (Nasdaq: SRDX) publiera ses résultats financiers pour le deuxième trimestre de l'exercice 2024 le 1er mai, accompagnés d'une webdiffusion en direct et d'une conférence téléphonique pour discuter des réalisations. L'appel sur les résultats aura lieu à 7h00 (CT) et pourra être accédé via le site Web de la société. Un replay audio sera disponible jusqu'au 15 mai.
Surmodics, Inc. (Nasdaq: SRDX) wird am 1. Mai seine Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2024 bekannt geben, begleitet von einem Live-Webcast und einer Telefonkonferenz, um die Errungenschaften zu diskutieren. Der Ergebnisanruf findet um 7:00 Uhr (CT) statt und ist über die Website des Unternehmens zugänglich. Eine Audio-Wiedergabe wird bis zum 15. Mai verfügbar sein.
Positive
None.
Negative
None.
Earnings Conference Call and Webcast Will Begin at 7:00 am (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 1.
Management will host a live webcast and conference call at 7:00 a.m. CT (8:00 a.m. ET) on Wednesday, May 1, to discuss the second quarter fiscal 2024 financial results and accomplishments and host a question-and-answer session. To access the webcast, please go to “Events & Presentations” under the “Investors” section of the Company’s website at https://surmodics.gcs-web.com/events-and-presentations, and click on the webcast icon under “Upcoming Events.” To listen to the live teleconference, please dial 877-407-8293 (international callers may dial +1 201-689-8349) and provide event ID 13745933.
An audio replay of the conference call will be available beginning at approximately 11 a.m. CT on Wednesday, May 1, until approximately 11 a.m. CT on Wednesday, May 15, and can be accessed by dialing 877‑660‑6853 (international callers may dial 201-612-7415) and entering access ID 13745933. In addition, the webcast and transcript will be archived on the Company’s website following the call.
About Surmodics, Inc.
Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities. The Company’s mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the Securities and Exchange Commission.
Surmodics Investor Inquiries:
Jack Powell, Investor Relations
ir@surmodics.com
Source: Surmodics, Inc.
FAQ
When will Surmodics report its second quarter of fiscal 2024 financial results?
Surmodics will report its second quarter of fiscal 2024 financial results on May 1.
What is the ticker symbol for Surmodics?
The ticker symbol for Surmodics is SRDX.
How can I access the live webcast and conference call for Surmodics' earnings report?
To access the webcast, go to the 'Events & Presentations' section of the Company's website at https://surmodics.gcs-web.com/events-and-presentations and click on the webcast icon under 'Upcoming Events'. To join the conference call, dial 877-407-8293 (international callers may dial +1 201-689-8349) and provide event ID 13745933.
How long will the audio replay of the conference call be available?
The audio replay of the conference call will be available from approximately 11 a.m. CT on Wednesday, May 1, until approximately 11 a.m. CT on Wednesday, May 15. You can access it by dialing 877-660-6853 (international callers may dial 201-612-7415) and entering access ID 13745933.
Where can I find the archived webcast and transcript of the earnings call?
The webcast and transcript will be archived on the Company's website following the call.
surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
